Yao Ding

454 total citations
33 papers, 321 citations indexed

About

Yao Ding is a scholar working on Epidemiology, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Yao Ding has authored 33 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Economics and Econometrics and 5 papers in Infectious Diseases. Recurrent topics in Yao Ding's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Economics and Policy (5 papers) and Vaccine Coverage and Hesitancy (3 papers). Yao Ding is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Economics and Policy (5 papers) and Vaccine Coverage and Hesitancy (3 papers). Yao Ding collaborates with scholars based in United States, China and United Kingdom. Yao Ding's co-authors include Scott D. Grosse, Michael Glass, Lisa Kobrynski, Jelili Ojodu, Rolin L. Wade, Arijit Ganguli, Nianwen Shi, Anthony Wang, William J. Sandborn and Marla C. Dubinsky and has published in prestigious journals such as Gastroenterology, Radiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Yao Ding

28 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao Ding United States 9 92 79 60 52 43 33 321
Ayako Shimada United States 13 48 0.5× 68 0.9× 170 2.8× 84 1.6× 53 1.2× 57 588
John Cheng United States 11 70 0.8× 18 0.2× 67 1.1× 57 1.1× 45 1.0× 23 429
Pierrick Le Borgne France 12 114 1.2× 70 0.9× 72 1.2× 33 0.6× 18 0.4× 61 454
Mark Ponsford United Kingdom 15 75 0.8× 65 0.8× 56 0.9× 220 4.2× 18 0.4× 32 580
Aarti Agarwal United States 11 46 0.5× 29 0.4× 57 0.9× 42 0.8× 26 0.6× 41 497
Catherine A. St. Hill United States 14 174 1.9× 18 0.2× 113 1.9× 118 2.3× 58 1.3× 33 717
Patrick Whelan United States 10 38 0.4× 17 0.2× 114 1.9× 26 0.5× 43 1.0× 26 382
Cătălina Mihai Romania 13 168 1.8× 125 1.6× 19 0.3× 29 0.6× 19 0.4× 70 516
Jordi Ara Spain 11 46 0.5× 31 0.4× 134 2.2× 27 0.5× 13 0.3× 23 542
Justin Kim United States 13 99 1.1× 18 0.2× 49 0.8× 29 0.6× 46 1.1× 49 589

Countries citing papers authored by Yao Ding

Since Specialization
Citations

This map shows the geographic impact of Yao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Ding more than expected).

Fields of papers citing papers by Yao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Ding. The network helps show where Yao Ding may publish in the future.

Co-authorship network of co-authors of Yao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Ding. A scholar is included among the top collaborators of Yao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Ding. Yao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xiaowu, Yi Yan, Yao Ding, et al.. (2025). Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study. Frontiers in Microbiology. 16. 1568615–1568615. 1 indexed citations
3.
Ding, Yao, et al.. (2024). Fractional-Order Modeling of COVID-19 Transmission Dynamics: A Study on Vaccine Immunization Failure. Mathematics. 12(21). 3378–3378. 2 indexed citations
4.
5.
Yeung, Kai, et al.. (2022). P1 Estimating US National Prescription Drug Savings from Applying Value-Based Price Caps. Value in Health. 25(7). S287–S287. 1 indexed citations
6.
7.
Álvarez, Enrique, Kavita Nair, Yao Ding, et al.. (2021). Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey. Multiple Sclerosis and Related Disorders. 50. 102858–102858. 1 indexed citations
8.
Hill, Steven, G. Edward Miller, & Yao Ding. (2020). Net Spending On Retail Specialty Drugs Grew Rapidly, Especially For Private Insurance And Medicare Part D. Health Affairs. 39(11). 1970–1976. 7 indexed citations
9.
Ding, Yao, et al.. (2019). <p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>. Patient Preference and Adherence. Volume 13. 1927–1939. 19 indexed citations
10.
Baker, Christine L., et al.. (2018). A cost&ndash;benefit analysis of smoking cessation prescription coverage from a US payer perspective. ClinicoEconomics and Outcomes Research. Volume 10. 359–370. 16 indexed citations
11.
Boklage, Susan, et al.. (2018). Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions. Cardiovascular Drugs and Therapy. 32(3). 273–280. 8 indexed citations
12.
13.
Grosse, Scott D., et al.. (2016). The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience. Milbank Quarterly. 94(2). 366–391. 31 indexed citations
14.
Ding, Yao, et al.. (2016). Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. The Journal of Pediatrics. 172. 127–135. 45 indexed citations
15.
Gadler, Fredrik, et al.. (2016). Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden. ClinicoEconomics and Outcomes Research. Volume 8. 657–666. 7 indexed citations
16.
Ding, Yao & Joel W. Hay. (2014). Economic Burden Associated With Patients Diagnosed With Peyronie’s Disease In The United States. Value in Health. 17(3). A157–A158.
17.
Ding, Yao, et al.. (2014). Cost-Effectiveness Comparison Of Denosumab And Zoledronic Acid In The Treatment Of Postmenopausal Osteoporosis. Value in Health. 17(3). A47–A47. 1 indexed citations
18.
Ding, Yao & Joel W. Hay. (2014). Impact of Maternal Education on Child Immunization Propensity in China. Value in Health. 17(7). A724–A725. 2 indexed citations
19.
20.
Ding, Yao, Kenneth M. Zangwill, Joel W. Hay, Norma J. Allred, & Sylvia H. Yeh. (2012). Cost-Benefit Analysis of In-Hospital Influenza Vaccination of Postpartum Women. Obstetrics and Gynecology. 119(2, Part 1). 306–314. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayako Shimada Breakdown of academic impact, for papers by John Cheng Breakdown of academic impact, for papers by Pierrick Le Borgne Breakdown of academic impact, for papers by Mark Ponsford Breakdown of academic impact, for papers by Aarti Agarwal Breakdown of academic impact, for papers by Catherine A. St. Hill Breakdown of academic impact, for papers by Patrick Whelan Breakdown of academic impact, for papers by Cătălina Mihai Breakdown of academic impact, for papers by Jordi Ara Breakdown of academic impact, for papers by Justin Kim
Rankless by CCL
2026